TERT-IN-1
CAS No. 257891-65-9
TERT-IN-1( —— )
Catalog No. M37513 CAS No. 257891-65-9
TERT-IN-1 has anti-HIV activity and can be used to study HIV infection.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 248 | Get Quote |
|
| 5MG | 376 | Get Quote |
|
| 10MG | 550 | Get Quote |
|
| 25MG | 820 | Get Quote |
|
| 50MG | 1122 | Get Quote |
|
| 100MG | 1485 | Get Quote |
|
| 200MG | 2007 | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameTERT-IN-1
-
NoteResearch use only, not for human use.
-
Brief DescriptionTERT-IN-1 has anti-HIV activity and can be used to study HIV infection.
-
DescriptionTERT-IN-1 has anti-HIV activity and can be used to study HIV infection.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayMicrobiology/Virology
-
TargetHIV
-
RecptorHIV Protease
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number257891-65-9
-
Formula Weight321.87
-
Molecular FormulaC16H20ClN3S
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESS=C1NC2=CC=C(Cl)C3=C2N1CC(N(CC=C(C)C)C3)C
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
HIV-1 integrase inhi...
HIV-1 integrase inhibitor is an HIV-1 integrase inhibitor.
-
PF-3450074
PF-3450074 (PF74) is a small molecule HIV capsid protein, destabilized the viral capsid in vitro; acts at an early stage of HIV-1 infection and inhibits reverse transcription in target cells.
-
HIV-1 inhibitor 18A
HIV-1 inhibitor 18A is a novel broad HIV-1 inhibitor that blocks envelope glycoprotein transitions critical for entry.
Cart
sales@molnova.com